Lin Yu, PhDManaging Director,
Healthcare Investment Banking
Lin Yu, PhD is a Managing Director within BTIG Healthcare Investment Banking, where he leads the firm’s Healthcare Royalty Monetization business. Prior to BTIG, Dr. Yu was a Principal on the Healthcare Private Equity Team at KKR dedicated to its royalty and private credit strategy. Previously, he was a Director of Investment Research and Analysis at DRI Capital, a healthcare royalty-focused private equity firm. Earlier in Dr. Yu’s career, he was an Equity Research Analyst covering medical devices and technologies at Cowen & Co. He earned a PhD and an MS from Columbia University in chemical engineering, where he focused his research on next-generation DNA sequencing technologies. Dr. Yu earned a BS in chemical engineering from The Cooper Union for Advancement of Science and Art.